inhibitory topoisomeras [Topoisomerase Inhibitors] tematický
- Termíny
-
DNA topoisomerasy - inhibitory
DNA-topoisomerasy - inhibitory
inhibitory topoisomerasy
inhibitory topoizomeráz
inhibitory topoizomerázy
topoisomerasy - inhibitory
-
DNA Topoisomerase Inhibitor
DNA Topoisomerase Inhibitors
Topoisomerase Inhibitor
Perzistentní odkaz
https://www.medvik.cz/link/D059003
Definice
Sloučeniny, které inhibují činnost DNA-TOPOISOMERAS.
Compounds that inhibit the activity of DNA TOPOISOMERASES.
Povolená podhesla
- AN
- analýza 0
- AD
- aplikace a dávkování 1
- CS
- chemická syntéza 1
- CH
- chemie 1
- HI
- dějiny 0
- EC
- ekonomika 0
- PK
- farmakokinetika 0
- PD
- farmakologie 3
- IM
- imunologie 0
- IP
- izolace a purifikace 0
- CL
- klasifikace 0
- BL
- krev 0
- ME
- metabolismus 1
- UR
- moč 0
- CF
- mozkomíšní mok 0
- ST
- normy 0
- PO
- otrava 0
- AE
- škodlivé účinky 0
- TU
- terapeutické užití 2
- TO
- toxicita 0
- RE
- účinky záření 0
- SD
- zásobování a distribuce 0
123
Výskyt v záznamech Medvik
D
Chemikálie a léčiva
D27
chemické látky - účinky a užití
D27.505 farmakologické účinky
D27.505.519 farmakologické účinky - molekulární mechanismy
D27.505.519.389 inhibitory enzymů
D27.505.519.389.086 inhibitory proteinu aktivujícího 5-lipoxygenasu
D27.505.519.389.089 inhibitory acetaldehyd dehydrogenasy
D27.505.519.389.092 inhibitory adenosindeaminasy
D27.505.519.389.108 inhibitory adenylylcyklasy
D27.505.519.389.124 inhibitory dekarboxylasy aromatických aminokyselin
D27.505.519.389.174 inhibitory kalcineurinu
D27.505.519.389.200 inhibitory karboanhydras
D27.505.519.389.237 inhibitory katechol-O-methyltransferasy
D27.505.519.389.275 cholinesterasové inhibitory
D27.505.519.389.310 inhibitory cyklooxygenasy
D27.505.519.389.315 inhibitory a modulátory gama-sekretázy
D27.505.519.389.320 inhibitory glykosidových hydrolas
D27.505.519.389.335 inhibitory cytochromu P450
D27.505.519.389.350 antagonisté kyseliny listové
D27.505.519.389.360 inhibitory histondeacetylas
D27.505.519.389.370 statiny
D27.505.519.389.375 inhibitory integrasy
D27.505.519.389.400 inhibitory beta-laktamasy
D27.505.519.389.480 inhibitory lipoxygenas
D27.505.519.389.616 inhibitory MAO
D27.505.519.389.675 inhibitory syntézy nukleových kyselin
D27.505.519.389.705 inhibitory ornithindekarboxylasy
D27.505.519.389.735 inhibitory fosfodiesteras
D27.505.519.389.736 inhibitory fosfoinositid-3-kinasy
D27.505.519.389.737 inhibitory fosfolipasy A2
D27.505.519.389.739 PARP inhibitory
D27.505.519.389.740 inhibitory prolylhydroxylas
D27.505.519.389.745 inhibitory proteas
D27.505.519.389.755 inhibitory proteinkinas
D27.505.519.389.760 inhibitory syntézy proteinů
D27.505.519.389.848 inhibitory protonové pumpy
D27.505.519.389.870 inhibitory syntézy steroidů
D27.505.519.389.892 inhibitory topoisomeras
D27.505.519.389.892.500 inhibitory topoisomerasy I
D27.505.519.389.892.750 inhibitory topoisomerasy II
D27.505.519.389.936 rozpřahující látky
D27.505.954 terapeutické užití
D27.505.954.248 antitumorózní látky
D27.505.954.248.025 inhibitory angiogeneze
D27.505.954.248.106 antibiotika antitumorózní
D27.505.954.248.125 antikarcinogenní látky
D27.505.954.248.144 antimetabolity antitumorózní
D27.505.954.248.147 antimitotika
D27.505.954.248.150 antitumorózní látky alkylující
D27.505.954.248.169 antitumorózní látky hormonální
D27.505.954.248.179 antitumorózní látky fytogenní
D27.505.954.248.384 protinádorové látky imunologicky aktivní
D27.505.954.248.538 mTOR inhibitory
D27.505.954.248.589 myeloablativní agonisté
D27.505.954.248.692 PARP inhibitory
D27.505.954.248.794 inhibitory topoisomeras
D27.505.954.248.794.500 inhibitory topoisomerasy I
D27.505.954.248.794.750 inhibitory topoisomerasy II